Search research articles
Contact Us
Filters
Showing results (181-190 of 235) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
Sandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
Nicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
JAMA
|
April 8, 2020
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial
William D Tap, Andrew J Wagner, Patrick Schöffski, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Clinical Therapeutics
|
April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
Heather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
ESMO Open
|
July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
E Rosenbaum, K Seier, M Bradic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 235) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
Sandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
Nicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
JAMA
|
April 8, 2020
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial
William D Tap, Andrew J Wagner, Patrick Schöffski, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Clinical Therapeutics
|
April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
Heather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
ESMO Open
|
July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
E Rosenbaum, K Seier, M Bradic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Page
of 24